MSF To Begin Ebola Drug Trials In West Africa Next Month

News outlets report on issues surrounding Ebola drug trials and note Médecins Sans Frontières (MSF) will begin clinical trials for two Ebola drugs in West Africa beginning in December.

Nature: Ethical dilemma for Ebola drug trials (Hayden, 11/11).
New York Times: Researchers to Test New Treatments in Countries Hit Hardest by Ebola (Pollack, 11/12).
Reuters: MSF centers in Guinea and Liberia to test Ebola drugs next month (Kelland, 11/13).
Wall Street Journal: Trials of Two Antivirals to Treat Ebola Patients to Start Next Month (Loftus, 11/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.